Emmaus Life Sciences, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

SUBSEQUENT EVENTS (Details)

SUBSEQUENT EVENTS (Details) $ / shares in Units, ₩ in Millions		1 Months Ended											12 Months Ended
	Apr. 15, 2024 USD ($) $ / shares	May 31, 2024 USD ($)	Apr. 30, 2024 USD ($)	Apr. 30, 2024 KRW (₩)	Mar. 31, 2024 USD ($)	Nov. 30, 2023 USD ($)	Oct. 31, 2023 USD ($)	Jul. 31, 2023 USD ($)	May 31, 2023 USD ($)	Apr. 30, 2023 USD ($)	Apr. 30, 2023 KRW (₩)	Mar. 31, 2023 USD ($)	Dec. 31, 2023 USD ($) $ / shares	Dec. 31, 2022 USD ($)	Apr. 30, 2024 KRW (₩)	Jan. 01, 2024 USD ($)	Apr. 30, 2023 KRW (₩)	Jan. 31, 2023 USD ($) $ / shares
Subsequent Event [Line Items]
Net proceeds from related party loans													$ 927,000	$ 3,900,000
Wei Peu Zen [Member]
Subsequent Event [Line Items]
Principal amount													$ 700,000
Interest rate													5.00%
API Supply Agreement [Member] \| Telcon RF Pharmaceuticals, Inc. ("Telcon") [Member]
Subsequent Event [Line Items]
Offset amount against principal amount of convertible bond										$ 2,200,000							₩ 2,900
Cash proceeds to shortfall in revenue and profits										$ 236,000	₩ 307
Revenue Purchase Agreement [Member]
Subsequent Event [Line Items]
Sale of accounts receivable						$ 762,200	$ 1,377,500	$ 828,000	$ 528,200			$ 700,212
Proceeds from sale of notes receivable						468,650	875,000	300,000	368,600			$ 491,933
Amount agreed to pay weekly sales receipts until future receipt is delivered						$ 49,000	$ 81,000	$ 26,000	$ 19,000
Revenue Purchase Agreement [Member] \| Forecast [Member]
Subsequent Event [Line Items]
Sale of accounts receivable		$ 1,628,000
Proceeds from sale of notes receivable		1,001,000
Amount agreed to pay weekly sales receipts until future receipt is delivered		$ 58,143
Convertible Promissory Note [Member] \| Wei Peu Zen [Member]
Subsequent Event [Line Items]
Principal amount																		$ 1,000,000
Interest rate																		10.00%
Conversion price \| $ / shares													$ 0.29					$ 0.5
Subsequent Event [Member] \| API Supply Agreement [Member] \| Telcon RF Pharmaceuticals, Inc. ("Telcon") [Member]
Subsequent Event [Line Items]
Offset amount against principal amount of convertible bond			$ 2,500,000												₩ 3,500
Cash proceeds to shortfall in revenue and profits			$ 640,000	₩ 893
Subsequent Event [Member] \| Convertible Promissory Note [Member]
Subsequent Event [Line Items]
Interest rate	10.00%
Conversion price \| $ / shares	$ 0.13
Subsequent Event [Member] \| Convertible Promissory Note [Member] \| Exchange Agreement [Member]
Subsequent Event [Line Items]
Principal amount	$ 11,100,000
Maturity year	2024				2025
Interest rate	2.00%
Conversion price \| $ / shares	$ 0.13
Subsequent Event [Member] \| Demand Promissory Notes [Member]
Subsequent Event [Line Items]
Principal amount																$ 2,800,000
Subsequent Event [Member] \| Smart Start Investments Limited [Member] \| Wei Peu Zen [Member]
Subsequent Event [Line Items]
Principal amount					$ 1,400,000
Interest rate					2.50%
Percentage of shareholding ownership held					9.96%